期刊文献+

全麻状态下颅内动脉瘤夹闭术患者脑脊液中促红细胞生成素的变化

Changes of erythropoietin in cerebrospinal fluid of patients undergoing clipping of intracranial aneurysm
下载PDF
导出
摘要 目的观察颅内动脉瘤夹闭术患者围术期全身麻醉后不同时间点的促红细胞生成素(EPO)的变化规律。方法随机选择ASAⅠ-Ⅲ级颅内动脉瘤夹闭术患者30例,Hunt-Hess分级Ⅰ-Ⅲ级,静吸复合全身麻醉,腰穿取不同时间点(麻醉诱导后、动脉瘤夹闭后即刻,术后2,4和24h)采集脑脊液,用酶联免疫吸附法检测脑脊液的EPO浓度。结果30例患者2例术后24h死亡,他们的EPO值均高于同期研究者数倍,余28例不同时间点EPO值由高到低依次为:术后2h>动脉瘤夹闭后即刻>术后4h>术后24h>麻醉诱导后,麻醉诱导后和各不同时间点间比较均有统计学差异。结论颅内动脉瘤夹闭术患者EPO的升高与术中机体受到伤害性刺激的损伤程度相一致,EPO应激性升高可能起脑保护作用,但体内的EPO并不能逆转损伤的进程。 Objective To investigate the changes of erythropoietin (EPO) in cerebrospinal fluid in patients undergoing clipping of intracranial aneurysm. Methods Thirty ASA Ⅰ-Ⅲ patients undergoing clipping of intracranial aneurysm were anesthetized. After tra- cheal intubation,lumbar puncture was performed in patients. The levels of EPO in cerebrospinal fluids were determined after by enzyme linked immunosorbent assay(ELISA) intubation, at the time of clipping aneurysm, at hour 2, 4,24 after surgery, respectively. Results Of 30 patients ,two patients died after surgery,with higher EPO than that of the others. The EPO levels decreased at hour 2 after surgery, clipping aneurysm, at hour 4 after surgery, at hour 24 after surgery, after tracheal intubation in turns. Compared with that after tracheal intubation ,EPO level showed a significant difference at the other time points. Conclusion The EPO level is coincident with the degree of surgery injury, and the increase of EPO may be favorable to neuroprotection. However, endogenous EPO could not reverse the development of the injury.
出处 《山西医科大学学报》 CAS 2009年第1期78-80,共3页 Journal of Shanxi Medical University
关键词 促红细胞生成素 颅内动脉瘤 脑脊液 脑保护 erythropoietin intracranial aneurysm cerehrospinal fluid neuroprotection
  • 相关文献

参考文献1

二级参考文献47

  • 1Li F, Chong ZZ, Maiese K. Erythropoietin on a tightrope: balancing neuronal and vuscular protection between intrinsic and extrinsic pathways. Neurosignals 2004; 13: 265-89.
  • 2Broudy VC, Lin N, Brice M, Nakamoto B. Papayannopoulou T. Erythropoietin receptor characteristics on primary human erythroid cells. Bolld 1991;77:2583-90.
  • 3Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med 2003; 228:1-14.
  • 4Maiese K, Li F, Chong ZZ. New avenues for exploration of erythropoietin. JAMA 2005; 295:90-5.
  • 5Brines M, Cerami A. Emerging biological roles for erythropoletin in the nervous system. Nat Rev Neurosci 2005; 6: 484-94.
  • 6Anagnostoo A, Liu Z, Steiner M, Chin K, Lee ES, Kesseimian N, et al. Erythropoietin receptor mRNA expression in human cndothelial cells. Proc Natl Acad Sci USA 1994; 91:3974-8.
  • 7Gogusev J, Zhu DLm, Herembert T. Ammarguellat F, Marche P, Drucke T. Effect of erythropoietin on DNA synthesis. protooncogene expression and hospholipase C activity in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1994; 199: 977-83.
  • 8Ammargucllat F, Gogusev J, Drueke TB. Direct effect of erythropoietin receptor. Nephrol Dial Transplant 1996; 11: 687-92.
  • 9Wald MR, Borda ES, Sterin-Borda L. Mitogenic effect of crythropoietin on neonatal rat cardiomyocytes: Signal transduction pathways. J Cell Physiol 1996;167: 461-6.
  • 10Morakkabati N, Gollnick F, Meyer R, Fandrey J, Jelkmann W. Erythropoietin induces Ca^2+ mobilization and contraction in rat mesangial and aortic smooth muscle cultures. Exp Hematol 1996; 24: 392-7.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部